Prevalence of chronic disorders, expanding geriatric population, increased hospitalization, growth in the number of surgeries, and increasing adoption of advanced products is dynamically governing the global infusion pump market.
The demand for infusion pumps is increasing significantly due to increasing number of inpatients for treatment of chronic disorders such as cancer. According to the World Health Organization and the International Agency for Research on Cancer, in 2018, approximately 18 million new cancer cases were detected with a death toll of 9.6 million.
Additionally, the expansion in the global geriatric population is another factor boosting adoption of infusion pumps fueled by increased hospitalization and critical care requirement for elderly population. The demand for refurbished infusion pumps has witnessed prominent growth during the latter half of last decade from the mid-income and low-income countries. This has significantly impacted the growth of the global infusion pumps.
However, with increasing investment in healthcare infrastructure, the demand for advanced infusion pumps is expected to grow in coming years. Another factor shaping the global infusion pump market includes the rising merger and acquisition activities globally. The global infusion pump market is anticipated to witness significant growth during the forecast period.
North America contributed the largest share to the global infusion pump market in 2019 and is anticipated to be a dominating geography during the forecast period. Among the surgical procedures performed globally, the United States accounts for a major share due to prevalence of chronic disorders and expanding population. Increasing incidences of cancer, prevalence of infectious diseases, and adoption of ambulatory infusion pumps are the key factor contributing towards the demand for infusion pumps in North America.
Asia Pacific is anticipated to offer lucrative opportunities to the manufacturers of infusion pumps in coming years owing to the expanding population, and rising investment in strengthening the healthcare infrastructure. The growth of healthcare tourism and prevalence of chronic diseases are anticipated to be the key attributes towards the growth of Asia Pacific infusion pump market during the forecast period.
The report titled “Infusion Pump Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is the historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global infusion pump market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Becton, Dickinson and Company reported revenues of USD 17.3 billion in 2019 and the product segment analysis of the company indicates that BD Medical business segment of the company dominated revenue in 2019.
The global infusion pump market is segmented based on type, product type, application, end user, and geography. Based on type, the global infusion pump market is segmented into traditional infusion pumps, and specialty infusion pumps. Based on product type, the global infusion pump market is segmented into volumetric infusion pumps, enteral infusion pumps, ambulatory infusion pumps, syringe infusion pumps, insulin infusion pumps, PCA pumps, implantable infusion pumps, and others. The ambulatory infusion pumps are sub-segmented into disposable infusion pumps, and chemotherapy infusion pumps. Based on applications, the global infusion pump market is segmented into chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other. Based on end user, the global infusion pump market is segmented into hospitals, home care settings, ambulatory care settings, and others. Based on geography, the global Infusion Pump market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on infusion pumps. Further, market share of prominent companies in the global infusion pump market would also be estimated. For instance, Becton, Dickinson and Company operates through three business segments namely BD Medical, BD Life Sciences, and BD Interventional. The infusion pumps are delivered under BD Medical business segment of the company with revenue contribution of US$ 9.1 billion in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the infusion pump manufacturers. The global infusion pump market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the infusion pump business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global infusion pump market.
Major players active in the global infusion pump market include Avanos Medical, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Fresenius Kabi, ICU Medical, Inc., Insulet Corporation, JMS Co., Ltd., Medtronic plc, Micrel Medical Devices SA, Mindray Medical International Limited, Moog Inc., NIPRO Corporation, Roche Diagnostics, Smiths Medical, Tandem Diabetes Care, Inc., Teleflex, Inc., Terumo Corporation, Ypsomed Holding AG, and Zyno Medical.
Market Segmentation:
By Product Type
By Application
By Geography:
Prevalence of chronic disorders, expanding geriatric population, increased hospitalization, growth in the number of surgeries, and increasing adoption of advanced products is dynamically governing the global infusion pump market.
North America contributed the largest share to the global infusion pump market. Increasing incidences of cancer, prevalence of infectious diseases, and adoption of ambulatory infusion pumps are the key factor contributing towards the demand for infusion pumps in North America.
The infusion pump market is anticipated to expand at a CAGR of 6.9% from 2023 to 2032.
B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Roche Diagnostics and Medtronic plc are the top 5 infusion pump manufacturers.
The infusion pump market was valued at US$ 9.2 billion in 2021.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved